OAM
LCTX icon

Oxford Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History

Oxford Asset Management’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-39,842
Closed -$35K – 793
2019
Q4 		$35K Sell
39,842
-110,822
-74% -$92.3K ﹤0.01% 1679
2019
Q3 		$148K Buy
150,664
+17,851
+13% +$18.5K ﹤0.01% 1603
2019
Q2 		$146K Sell
132,813
-28,465
-18% -$32.8K ﹤0.01% 1589
2019
Q1 		$211K Buy
161,278
+45,869
+40% +$57.1K ﹤0.01% 1498
2018
Q4 		$105K Buy
+115,409
New +$177K ﹤0.01% 1645
2017
Q2 		– Sell
-16,822
Closed -$51K – 1595
2017
Q1 		$51K Buy
+16,822
New +$47.8K ﹤0.01% 1374
2015
Q3 		– Sell
-140,390
Closed -$411K – 678
2015
Q2 		$411K Buy
+140,390
New +$544K 0.01% 547

Other funds holding LCTX

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
NFC
Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return